1 Min Read
Dec 14 (Reuters) - Intelgenx Technologies Corp -
* IntelGenx and Redhill Biopharma announce definitive agreement for commercialization of Rizaport(r) for migraines with Pharmatronic Co in South Korea Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.